EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antiseizure medication withdrawal risk estimation and recommendations: A survey of American Academy of Neurology and EpiCARE members

Samuel W Terman iD, Renate van Griethuysen iD, Carole E Rheaume, Geertruida Slinger iD, Anisa S Haque, Shawna N Smith, Wesley T Kerr, Charlotte van Asch, Willem M Otte iD, Carolina Ferreira-Atuesta, Marian Galovic, James F Burke und 1 weitere

Epilepsia Open · 2023-06 · 8 (2) · 386-398

DOI: 10.1002/epi4.12696 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia Open, online erschienen am 14.02.2023. Verfasst von Samuel W Terman und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Epilepsy, Absence, Substance Withdrawal Syndrome, Neurology. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, NIA NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Choosing candidates for antiseizure medication (ASM) withdrawal in well‐controlled epilepsy is challenging. We evaluated (a) the correlation between neurologists' seizure risk estimation (“clinician predictions”) vs calculated predictions, (b) how viewing calculated predictions influenced recommendations, and (c) barriers to using risk calculation.

Methods

We asked US and European neurologists to predict 2‐year seizure risk after ASM withdrawal for hypothetical vignettes. We compared ASM withdrawal recommendations before vs after viewing calculated predictions, using generalized linear models.

Results

Three‐hundred and forty‐six neurologists responded. There was moderate correlation between clinician and calculated predictions (Spearman coefficient 0.42). Clinician predictions varied widely, for example, predictions ranged 5%‐100% for a 2‐year seizure‐free adult without epileptiform abnormalities. Mean clinician predictions exceeded calculated predictions for vignettes with epileptiform abnormalities (eg, childhood absence epilepsy: clinician 65%, 95% confidence interval [CI] 57%‐74%; calculated 46%) and surgical vignettes (eg, focal cortical dysplasia 6‐month seizure‐free mean clinician 56%, 95% CI 52%‐60%; calculated 28%). Clinicians overestimated the influence of epileptiform EEG findings on withdrawal risk (26%, 95% CI 24%‐28%) compared with calculators (14%, 95% 13%‐14%). Viewing calculated predictions slightly reduced willingness to withdraw (−0.8/10 change, 95% CI −1.0 to −0.7), particularly for vignettes without epileptiform abnormalities. The greatest barrier to calculator use was doubting its accuracy (44%). Significance Clinicians overestimated the influence of abnormal EEGs particularly for low‐risk patients and overestimated risk and the influence of seizure‐free duration for surgical patients, compared with calculators. These data may question widespread ordering of EEGs or time‐based seizure‐free thresholds for surgical patients. Viewing calculated predictions reduced willingness to withdraw particularly without epileptiform abnormalities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epilepsy, AbsenceSubstance Withdrawal SyndromeNeurologyAdultHumansChildAnticonvulsantsRecurrenceSeizures

Stichwörter der Autor:innen

antiseizure medicationsdiscontinuationepilepsysurvey

Substanzen

Anticonvulsants

Autor:innen und Institutionen

  • Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA.
  • Department of Clinical Neurophysiology and Sleep Centre, SEIN, Zwolle, The Netherlands.
  • American Academy of Neurology, Minneapolis, Minnesota, USA.
  • Department of Child Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, member of ERN EpiCARE, Utrecht University, Utrecht, The Netherlands.
  • University of Michigan Medical School, Ann Arbor, Michigan, USA.
  • Department of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor, Michigan, USA.

ORCID-Profile: Samuel W Terman, Renate van Griethuysen, Geertruida Slinger, Willem M Otte

Förderung

  • NCATS NIH HHS
  • NIA NIH HHS
  • NINDS NIH HHS
  • American Academy of Neurology
  • American Epilepsy Society
  • Michigan Institute for Clinical and Health Research
  • National Institutes of Health

Zitieren

APA

Terman, S. W., van Griethuysen, R., Rheaume, C. E., Slinger, G., Haque, A. S., Smith, S. N., Kerr, W. T., van Asch, C., Otte, W. M., Ferreira-Atuesta, C., Galovic, M., Burke, J. F., & Braun, K. P. J. (2023). Antiseizure medication withdrawal risk estimation and recommendations: A survey of American Academy of Neurology and EpiCARE members. Epilepsia Open, 8(2), 386-398. https://doi.org/10.1002/epi4.12696

Vancouver

Terman SW, van Griethuysen R, Rheaume CE, Slinger G, Haque AS, Smith SN, et al. Antiseizure medication withdrawal risk estimation and recommendations: A survey of American Academy of Neurology and EpiCARE members. Epilepsia Open. 2023;8(2):386-398. doi:10.1002/epi4.12696

BibTeX
@article{Terman2023,
  author = {Terman, Samuel W and van Griethuysen, Renate and Rheaume, Carole E and Slinger, Geertruida and Haque, Anisa S and Smith, Shawna N and Kerr, Wesley T and van Asch, Charlotte and Otte, Willem M and Ferreira-Atuesta, Carolina and Galovic, Marian and Burke, James F and Braun, Kees P J},
  title = {Antiseizure medication withdrawal risk estimation and recommendations: A survey of American Academy of Neurology and EpiCARE members},
  journal = {Epilepsia Open},
  year = {2023},
  volume = {8},
  number = {2},
  pages = {386--398},
  doi = {10.1002/epi4.12696}
}
Kostenlos starten →